5 Best Low-Risk Investments in May 2026

In this article, we will take a look at the 5 Best Low-Risk Investments in May 2026. For a deeper discussion and an expanded list, please see 10 Best Low-Risk Investments in May 2026.

5. Altria Group, Inc. (NYSE:MO)

Altria Group, Inc. (NYSE:MO) ranks among the best low-risk investments in May 2026. Following investor meetings with company management, Stifel reaffirmed its Buy rating and $68 price target on Altria Group, Inc. (NYSE:MO) on March 31. The firm’s earnings growth forecast is supported by a moderate decline in the tobacco market and Altria’s ability to control revenue growth.

5 Best Low-Risk Investments in May 2026

Jonathan Weiss/Shutterstock.com

Altria Group, Inc. (NYSE:MO) is actively rolling out its newly authorized on! PLUS nicotine pouches on a national level. In the short run, the company plans to leverage promotional pricing to drive trial in the rapidly growing market.

In a similar vein, Jefferies named Altria Group, Inc. (NYSE:MO) one of its top tobacco stocks on April 1. The company’s on! brand saw volume reductions in March while maintaining strong pricing. Volumes and value declined 15.5% and 5.2%, respectively, compared with 17.6% reductions in February and a 1.2% value increase.

The price per unit increased to $4.60, well above the 52-week average of $3.00, which Jefferies believes could be an indicator of on! Plus’s premium pricing strategy, which seems more in line with Velo and ZYN.

Altria Group, Inc. (NYSE:MO) is a prominent American company that produces and markets tobacco, cigarettes, and related products globally. The firm has also ventured into next-generation nicotine products, such as oral nicotine pouches and electronic vaping devices.

4. The Progressive Corporation (NYSE:PGR)

The Progressive Corporation (NYSE:PGR) ranks among the best low-risk investments in May 2026. On April 15, BofA Securities boosted The Progressive Corporation (NYSE:PGR)’s price target to $312 from $298, while keeping a Buy rating on the company’s stock. The firm’s March quarter earnings were $1.55 per share, lower than BofA’s prediction of $1.62 but consistent with industry expectations. The in-period loss ratio exceeded the firm’s projection, although net prior-period development was greater than predicted.

Progressive’s expense ratio fell to 20.0% in March from 20.6%-20.9% in previous months, indicating increased cost efficiency, possibly due to reduced advertising expenditures or a more stable workforce. This operational discipline strengthens the company’s adaptability to changing market conditions.

Based on the March data, BofA reduced its fiscal 2026 full-year forecast for The Progressive Corporation (NYSE:PGR), though it increased its out-year projections by 10 cents because of a slightly higher estimate of stock buybacks at a marginally lower price. Using an underwriting-margin-normalized 92% combined ratio, the firm’s 2028 prediction of $19.40 per share would change to $16.81 per share.

The Progressive Corporation (NYSE:PGR) is an insurance holding company that provides residential property insurance, personal and commercial auto insurance, and other specialty property-casualty insurance and related services.

3. Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) ranks among the best low-risk investments in May 2026. On April 13, Guggenheim reaffirmed a Buy rating and a $36 price target for Pfizer Inc. (NYSE:PFE) as the firm revised its financial forecast ahead of the company’s Q1 earnings announcement on May 5.

The firm anticipates first-quarter revenues of around $13.8 billion, compared to average predictions of $13.9 billion, and earnings per share of $0.76 vs $0.72. Full-year 2026 revenue and EPS expectations come in at $61.3 billion and $3, respectively, contrary to the consensus of $61.2 billion and $2.96.

The key adjustment in Guggenheim’s forecast is a substantial upward adjustment to Eliquis, which the firm thinks has better IRA net price dynamics than the market projected.

Guggenheim anticipates investor attention to focus on impending pipeline readouts, which the firm thinks will help drive expansion for the company as it deals with the 2026-2028 era of major patent expirations.

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the US and internationally. The company offers medicines and vaccines in various therapeutic areas.

2. PepsiCo, Inc. (NASDAQ:PEP)

PepsiCo, Inc. (NASDAQ:PEP) ranks among the best low-risk investments in May 2026. PepsiCo, Inc. (NASDAQ:PEP) stands out as a stable, low-risk investment option thanks to its steady earnings performance and defensive business model. Following solid first-quarter earnings, UBS confirmed its Buy rating and set a price target of $186 for the company’s shares on April 17.

The company reported earnings per share of $1.61, above expectations of $1.55, and revenue of $19.44 billion, exceeding projections of $18.94 billion. This increase was driven by strong organic revenue growth and enhanced cost control, which served to offset pressure on gross margins.

Similarly, RBC Capital reiterated its Sector Perform rating and $163 price target for PepsiCo, Inc. (NASDAQ:PEP). The firm stated that the company delivered strong performance globally, with a volume spike in its PFNA division.

PepsiCo, Inc. (NASDAQ:PEP) is relatively well shielded from cost pressures for the rest of 2026 because of hedging initiatives, allowing the company to uphold its bottom-line forecast. However, the firm stated that the boost in PFNA will need to be maintained in a more challenging macroeconomic scenario.

One of the most well-known names in the world, PepsiCo, Inc. (NASDAQ:PEP) is an American multinational company involved in the food, snack, and beverage sectors.

1. Verizon Communications Inc. (NYSE:VZ)

Verizon Communications Inc. (NYSE:VZ) ranks among the best low-risk investments in May 2026. On March 31, Barclays analysts stated that Verizon Communications Inc. (NYSE:VZ) is facing higher performance demands due to recent competitor moves and stock resets, with Q1 results serving as a crucial indicator of strategic implementation.

The company is aiming for 750,000 to 1 million postpaid phone net additions, indicating a push for significant year-over-year growth. The first-quarter results are likely to be a major signal of Verizon’s ability to successfully execute its plan in an increasingly competitive environment.

In broadband, Verizon Communications Inc. (NYSE:VZ) is expected to profit from modifications linked to its acquisition of Frontier Communications, with promotional activities anticipated to drive subscriber growth beyond the 85,000 to 100,000 increase Frontier has typically achieved in Q1.

While the first quarter is traditionally a slower season, analysts anticipate stronger subscriber growth than last year and a successful fourth quarter of 2025. There may still be some pressure, especially with regard to churn, but Verizon’s recurring revenue model and infrastructure-driven business make it a safe, steady choice for cautious investors.

Verizon Communications Inc. (NYSE:VZ) is a leading provider of technology, entertainment, and communications services worldwide.

While we acknowledge the potential of VZ to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than VZ and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: Starter Stock Portfolio: 14 Safe Stocks to Buy Now and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.